Abstract

Streptomyces lincolnensis is a producer of lincomycin, which is a lincosamide antibiotic for the treatment of infective diseases caused by Gram-positive bacteria. S. lincolnensis is refractory to introducing plasmid DNA into cells because of resistance of foreign DNAs and poor sporulation. In this study, a simple and efficient method of transferring plasmids into S. lincolnensis through the intergeneric Escherichia coli-mycelia conjugation was established and optimized for the first time. The recipient mycelia of S. lincolnensis were prepared in liquid SM medium containing 10.3% sucrose for three days. The dispersed mycelia were conjugated with competent E. coli donor cells. The exconjugants were regenerated efficiently on solid mannitol soya flour (MS) medium containing 20 mM MgCl2. The average conjugation frequency was observed at 1.1 × 10−4 per input donor cell and validated functionally by transferring two types of vectors containing lincomycin resistance genes lmrA, lmrB and lmrC into S. lincolnensis mycelia. The data of fermentation in shaking flasks showed the lincomycin yield of the exconjugants increased by 52.9% for the multiple copy vector and 38.3% for the integrative one, compared with the parental strain. The efficient and convenient method of intergeneric E. coli-mycelia conjugation in this study provides a promising procedure to introduce plasmid DNA into other refractory streptomycetes.

Highlights

  • Lincomycin and its 7-chloro-7-deoxy derivative clindamycin are lincosamide antibiotics composed of propylproline and methylthiolincosamide [1]

  • E. coli ET12567/pUZ8002 was used as the donor cells in the following studies to determine the optimal condition for intergeneric conjugation

  • As in the protoplast transformation in other Streptomyces [7,23,24], the concentration of sucrose added in the liquid medium was an effective factor for mycelia competence of S. lincolnensis

Read more

Summary

Introduction

Lincomycin and its 7-chloro-7-deoxy derivative clindamycin are lincosamide antibiotics composed of propylproline and methylthiolincosamide [1]. Lincomycin, produced by Streptomyces lincolnensis, is used as a major antibiotic for the treatment of diseases caused by Gram-positive bacteria [1]. Clindamycin is usually used to treat infections caused by anaerobic bacteria and some protozoal diseases, such as malaria, infections of the respiratory tract, skin and soft tissue infections, and peritonitis [2]. The importance of fermentative production of lincosamide antibiotics [6] and the lack of efficient techniques to introduce plasmid DNA into S. lincolnensis, have encouraged the development of an efficient DNA manipulation technology to improve productivity and to analyze functionality of the secondary metabolite genes of interest in S. lincolnensis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call